Collectively, our results indicate that VCC-1 is a downstream regulator of OCT4 and is a promising biomarker and therapeutic target for lung cancer, emphasizing the critical roles of OCT4 and VCC-1 in cancer development. The gene discussed is CXCL17; the disease is lung cancer.